(Q74608840)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

1 reference

A C Altamura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Bassetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F Sassella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D Salvadori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

E Mundo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

published in

Schizophrenia Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

29-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Negative symptoms in schizophrenia. Definition and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

The family history method using diagnostic criteria. Reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Gender and the course of schizophrenia: differences in treated outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Premorbid adjustment as predictor of outcome in schizophrenia: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

The Prediction of Outcome in Schizophrenia IV

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Deficit and nondeficit forms of schizophrenia: the concept

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Learning from outcome studies. Toward a comprehensive biological-psychosocial understanding of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Evaluation of treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Molecular pathology of schizophrenia: more than one disease process?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

A randomised controlled trial of prophylactic neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Remission and relapse in schizophrenia: the Madras Longitudinal Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Early detection and intervention for initial episodes of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Qualitative MRI findings in patients with schizophrenia: a controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Deterioration in premorbid functioning in schizophrenia: a developmental model of negative symptoms in drug-free patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Expressed emotion and relapse in young schizophrenia outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Time course and biologic correlates of treatment response in first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Clinical and biological markers for outcome in schizophrenia: a review of a longitudinal follow-up study in Uppsala schizophrenia research project

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Duration of psychosis and outcome in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Predictors of shorter-, medium-, and longer-term outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

A selective review of recent North American long-term followup studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Classical Subtypes for Schizophrenia: Literature Review for DSM-IV

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

The positive-negative distinction in schizophrenia. Review of natural history validators

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Short-term outcome in trial entrants and trial eligible patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Predictors of outcome in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Psychotic relapse and maintenance therapy in paranoid schizophrenia: a 15 year follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Health care costs of therapy-refractory schizophrenic patients treated with clozapine: a study in a community psychiatric service in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Outcome of schizophrenia in relation to brain abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

The role of negative symptoms and cognitive dysfunction in schizophrenia outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Sociodemographic and clinical variables as predictors of the diagnostic characteristics of first episodes of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Neurocognitive deficits and neurological signs in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

13. Early intervention with neuroleptics may decrease the l long-term morbidity of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Clinical predictors of acute response with olanzapine in psychotic mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900187-0

7 January 2021

10.1016/S0920-9964(00)00187-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595389%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference